oxyphenisatine di(acetate) Chemical Properties

Melting point:

244℃

Boiling point:

566.5±50.0 °C(Predicted)

Density 

1.282±0.06 g/cm3(Predicted)

storage temp. 

-20°C Freezer

solubility 

Chloroform (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)

form 

Solid

pka

13.55±0.40(Predicted)

color 

White to Off-White

Safety Information

Toxicity

LD50 oral in rat: 1900mg/kg

oxyphenisatine di(acetate) Usage And Synthesis

Originator

Lavema,Winthrop,US,1959

Uses

Oxyphenisatin Diacetate is the pro-drug of Oxyphenisatin (O876965). Results confirm that Oxyphenisatin Diacetate inhibits the growth of breast cancer cell lines MCF7, T47D, HS578T, and MDA-MB-468.

Uses

Laxative.

Definition

ChEBI: Oxyphenisatine acetate is a member of phenols and a benzoate ester.

Manufacturing Process

235 gravimetrical parts of acetic acid anhydride (90%) are poured over 106 gravimetrical parts of diphenolisatin (Berichte der Deutschen Chemischen Gesselschsft, 18, 1885, p. 2641) and the mixture is heated on the water-bath while stirring. The solid starting material temporarily dissolves almost entirely and shortly afterwards the reaction product turns into a crystalline paste. In order to complete the reaction the heating on the water-bath is continued for a short time and then the whole is left to get cold. The reaction product may, for instance, be separated in the following manner: To the cold reaction mixture is gradually added about the same volumetrical quantity of alcohol; in this manner the excess of acetic acid anhydride is destroyed and the paste becomes thinner. Then the fluid is drawn off and the product washed with alcohol. For complete cleansing another extraction is made with warm alcohol and the product crystallized, for instance, from 10 parts of acetic acid. The product represents a light, fine crystalline powder, which is difficultly soluble or even insoluble in the usual organic solvents. Its melting point lies at 242°C.

brand name

Isocrin (Parke-Davis); Lavema (Sterling Winthrop);Acelax;Acetalax;Alophen pills;Ameiax;Api-slender;Artzone;Belloform;Biivectan;Bisflatan;Boxogetten;Brocatine;Buta pirone;Buteril;Butofen;Butolfen;Bydolax;Chlofel;Chur-lax;Ciracen;Cirotex;Cirotyl;Contax;Critex;Curolax;Darmoletten;Deililax;Dialose plus;Diasatin;Ditinil;Ditmedol;Eulaxin;Evac-u-lax;Ex-lax pills;Febutolo;Fibutrox;Fim-a-mint;Fin-a-mint gum;Fisiolax;Flib 518;Inlax;Ipebutona;Isaaxan;Isaphenyn;Izaman;Laveman;Laxan-vomoxin;Laxaseptol;Laxem;Laxnormal;Laxocoleva;Laxon;Laxos;Laxyl;Med-laxan;Menabil complex;Muxol;Naleran;Neocervulax;Neo-favmadol;Neo-soldana;Nourilax;Nurilaksi;Obstilax;Otone;Oxybutazone;Phlogase;Phlogistol;Phlogont;Potsilo;Promassoletten;Prusol;Rheumapax;Rivolax;Schokilax;Syndian;Tanderil-alka;Tete-lax;Validil.

Therapeutic Function

Laxative

World Health Organization (WHO)

Oxyphenisatine acetate was widely used as a laxative after its cathartic activity was first described in 1925. In 1969 its use was first associated with cases of acute and chronic liver disease. This association is considered by some, but not all, national drug regulatory authorities to warrant the withdrawal from the market of preparations containing oxyphenisatine and its derivatives.

oxyphenisatine di(acetate)(115-33-3)Related Product Information

• 4-CUMYLPHENOL
• 2,2-DIPHENYLACETAMIDE
• 2,N-DIPHENYLACETAMIDE
• PIVALAMIDE
• ACETIC ACID 4-TERT-BUTYLPHENYL ESTER
• 4,4'-(1-Phenylethylidene) biphenol
• oxyphenisatine di(acetate)
• N-METHYLTRIMETHYLACETAMIDE
• 4-METHOXYPHENYLACETAMIDE
• 4-Hydroxyphenylacetamide
• BISPHENOL A DIACETATE
• Oxindole
• 4-ETHOXYPHENETHYLAMINE
• [2-(4-METHOXY-PHENYL)-ETHYL]-METHYL-AMINE
• (R)-(+)-1-(1-Naphthyl)ethylamine
• 3-METHYLOXINDOLE 96
• 1-METHOXY-4-(1-PHENYL-ETHYL)-BENZENE
• 4-METHOXY-N-PHENYL-BENZENEETHANAMINE